Here are relevant reports on : skin-care-market
-
Skin Grafting Systems Market by Product (Dermatome & Wound Debridement Devices), Type (Autograft & Allograft), Wound Type (Burns, Surgical Wounds, Diabetic, Venous, Pressure Ulcers) & End User (Hospitals) - Global Forecast to 2023
The global skin grafting systems market is expected to reach USD 1,170 million by 2023 from USD 895 million in 2018, growing at a CAGR of 5.5%. Skin grafting is a novel technological advancement to surgical procedure which covers skin replacement from the healthy area of skin and providing coverage for wound area. Skin grafting is majorly used in different wound indications such as deep burns, injury, skin cancer or reconstructive surgeries and skin cancer. Increasing prevalence and incidences of burns injuries, leg ulcers including pressure and diabetic foot ulcer and skin infections leading to prolonged hospitalization is influencing the demand of skin grafting systems market. Also, Technological innovations in dermatomes such as development of electric and air dermatomes and increased precision are the factors expected to boost the market for skin grafting system. However, this market growth may be hampered owing to the factors such as lack of advanced healthcare infrastructure and poor healthcare accessibility in low income countries.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Derma Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030
The global derma fillers market, valued at US$3.74 billion in 2024, stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$ 7.32 billion by the end of the period. The key factors driving the derma fillers market are the demand for non-invasive procedures, social media celebrity influence, technological innovation and advancement, an aging population, rising disposable incomes, and increased interest in personalized treatments.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Surgical Staplers Market by Type (Linear, Circular, Skin, Curved), Technology (Manual, Powered), Usability (Disposable, Reusable), Application (Abdominal & Pelvic Surgery, General Surgery, Orthopedic Surgery), End User (Hospitals) - Global Forecast to 2029
The global surgical staplers market, valued at US$4.83 billion in 2023, stood at US$5.15 billion in 2024 and is projected to advance at a resilient CAGR of 7.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.29 billion by the end of the period. Several factors, including technological advancements in surgical staplers, an increasing focus on minimally invasive surgeries over traditional surgeries, and healthcare expansion in emerging markets, drive market growth.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Wellness Supplements Market by Product (Dietary Supplements (Vitamin, Mineral, Protein, Herbal), Functional/Fortified Food & Beverages, Food Intolerance (Gluten-Free, Lactose-Free), Dermo-Cosmetic Skin Essentials (Anti-Acne)) - Global Forecast to 2020
The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period. The growth of wellness supplement is mainly driven by factors such as rising geriatric population, growing prevalence of chronic diseases, rising awareness about benefits of wellness supplements, rising healthcare costs, and shift of consumers from care to preventive. However, regulatory compliance is likely to restrain the growth of wellness supplement market to a certain extent.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Botulinum Toxins Market by Product (Botox, Dysport, Jeuveau, Myobloc), Application (Cosmetic (Wrinkle Removal, Contouring, Skin rejuvenation), Therapeutic (OAB, Migraine, Spasm, Pain)), Volume, End User (Clinics, Center), Region - Global Forecast to 2030
The global botulinum toxins market, valued at US$8.1 billion in 2024, stood at US$8.9 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2025 to 2030, culminating in a forecasted valuation of US$15.7 billion by the end of the period.The rising societal emphasis on maintaining a youthful appearance, especially within urban environments and professional contexts, is driving an increasing number of individuals to seek out cosmetic procedures, with botulinum toxins (commonly known as Botox) being among the most popular options.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Marine Collagen Market by Type (Type I, Type III), Application (Nutraceuticals, Cosmetic, Medical), Source (Skin, scales, and muscles, Bones & tendons), Animal and Region – Trends and Global Forecast to 2026
The global marine collagen market is expected to grow from USD 778 million in 2021 to USD 1,137 million by 2026, at a compound annual growth rate (CAGR) of 7.9% during the forecast period.Ashland (US), Darling Ingredients (US), Nitta Gelatin (US), Gelita (Germany), Italgelatine (Italy), Nippi Collagen (Canada), Weishardt (France), Titan Biotech Limited (India), Amicogen (South Korea), Seagarden (Norway), Lapi Gelatine (Italy), Tai Ai Peptide Group (China), Hangzhou Nutrition Biotechnology (China), ETChem (China), BHN (Japan), Certified Nutraceuticals (US), Jellagen (UK), NutraChoice (Malaysia), Ningbo Nutrition Food Technology (China), Ming Chyi Biotechnology (Taiwan).
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 12.7% from 2024 to 2029, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers) & Region - Global Forecast to 2026
The global hospital acquired infection control market growth is primed to transition from $29.1 billion in 2021 to $31.3 billion by 2026, showcasing a strong CAGR of 1.5%. The growth of this market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19.
- Published: August 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
